Bioter S.A. (ATH:BIOT)

Bioter Statistics

Total Valuation

Bioter has a market cap or net worth of EUR 3.45 million. The enterprise value is 192.75 million.

Market Cap	3.45M
Enterprise Value	192.75M

Important Dates

The next estimated earnings date is Friday, June 26, 2026.

Earnings Date	Jun 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioter has 16.73 million shares outstanding.

Current Share Class	16.73M
Shares Outstanding	16.73M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	51.42%
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 0.06.

PE Ratio	0.06
Forward PE	n/a
PS Ratio	8.86
PB Ratio	-0.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	0.06
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	3.54
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-58.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.78%
Return on Invested Capital (ROIC)	-3.92%
Return on Capital Employed (ROCE)	2.34%
Weighted Average Cost of Capital (WACC)	0.11%
Revenue Per Employee	97,250
Profits Per Employee	13.62M
Employee Count	4
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-155,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.90% in the last 52 weeks. The beta is -0.08, so Bioter's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-25.90%
50-Day Moving Average	0.21
200-Day Moving Average	0.25
Relative Strength Index (RSI)	49.59
Average Volume (20 Days)	6,557

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioter had revenue of EUR 389,000 and earned 54.49 million in profits. Earnings per share was 3.26.

Revenue	389,000
Gross Profit	155,000
Operating Income	-1.88M
Pretax Income	54.28M
Net Income	54.49M
EBITDA	-1.77M
EBIT	-1.88M
Earnings Per Share (EPS)	3.26

Balance Sheet

The company has 908,000 in cash and 133.72 million in debt, with a net cash position of -132.81 million or -7.94 per share.

Cash & Cash Equivalents	908,000
Total Debt	133.72M
Net Cash	-132.81M
Net Cash Per Share	-7.94
Equity (Book Value)	-84.99M
Book Value Per Share	-5.05
Working Capital	-121.65M

Cash Flow

Operating Cash Flow	55.49M
Capital Expenditures	n/a
Depreciation & Amortization	103,000
Net Borrowing	-56.97M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 39.85%, with operating and profit margins of -482.01% and 14,008.48%.

Gross Margin	39.85%
Operating Margin	-482.01%
Pretax Margin	13,954.24%
Profit Margin	14,008.48%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioter does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1,580.72%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 9, 2010. It was a reverse split with a ratio of 0.25.

Last Split Date	Aug 9, 2010
Split Type	Reverse
Split Ratio	0.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	4